The National Aspergillosis Centre is part of the Manchester Fungal Infection Group (MFIG) who have just published an important paper in the very prestigious Nature Communications journal.
Sara Gago in Paul Bowyer’s lab has characterised a mutation carried by people that researchers have found make their airways stickier, thus enabling Aspergillus spores to stick and grow. The implications for infection (ABPA) are pretty clear and the group have already discovered that this mutation is common in people with ABPA (28% of patients in this study had this mutation). This leads us straight to thinking about screening out people who are prone to infection as they carry this gene mutation. We can then pay special attention to prevent them getting ABPA. What this means for people who already have ABPA is less clear, but certainly suggests another target for treatment.
Share this post
Latest News posts
The Lung Health Research & Medicine Revolution
January 29, 2019
Clean Air and Lung Health
January 29, 2019
ERS Vision: Take the Active Option for your Health
January 29, 2019
Push-ups for Aspergillosis Research
January 29, 2019
What is Aspergillosis? – Fungal Infections & Symptoms
January 29, 2019
Aspergillosis & antibody testing
January 29, 2019
Patients Meeting – Rome 2010
January 29, 2019
Some health effects of mould exposure
January 29, 2019
Interview with CPA patient RW on long term antifungal treatments
January 29, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video